Over the past year, we've been actively driving change in the GLP-1 weight management space to help lower costs
For tendon repair, platelet-rich plasma (PRP) has more human trial data than BPC-157, though PRP evidence is also mixed
New insights into allergic rhinitis treatment: MSC nanovesicles targeting dendritic cells
Zepbound is a dual GIP and GLP-1 receptor agonist, which means it activates both incretin pathways to enhance blood sugar control and support effective, long-term weight loss
PlexusDx serves all 50 states, requires no insurance, and is HSA/FSA eligible
Herbal medicines and plant-based therapies, with their potential antioxidant and protective effects, may offer a more affordable and accessible alternative